New publications
Americans have approved the use of shockwave therapy
Last reviewed: 02.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
In the United States, the method of therapy using shock waves has been approved and can already be used in clinical practice.
This treatment method, which involves the use of shock waves, has been known for a relatively long time. However, the use of such a procedure was not possible in all countries: specialists doubted the effectiveness and safety of this type of therapy, so they were in no hurry to grant approval for its use in practice.
According to the latest data, the Food and Drug Administration has finally approved the use of a new American device designed to heal wounds. The device works on the principle of shock wave action.
The new device was developed by Sanuwave, and the device itself was called the Dermapace system. The main focus of the device is the treatment of wounds in diabetes.
Patients suffering from diabetes have a common problem - these are such frequent complications as sluggish trophic processes in the form of erosions and ulcers. Experiments have shown that an acoustic shock wave can accelerate wound healing and improve granulation by 14%.
These conclusions were made based on the results of the last clinical trial, which involved 336 patients.
One part of the patients underwent treatment with conventional methods, as well as with the use of a hardware simulator of shock wave therapy. The second part of the patients was offered the same conventional treatment, but with the use of the real Dermapace system device. Six months after the start of the experiment, the scientists made certain conclusions: the quality of healing in the participants of the first group was 30%, and in the participants of the second group - 44%.
Of course, it should be noted that the use of shock wave therapy is possible only against the background of traditional treatment of ulcerative processes in diabetes mellitus. In this case, the age of patients must be at least 22 years. And one more condition: the need to use shock waves arises only when the ulcer does not heal on its own for more than one month.
Experts also told about the possible side effects of shock wave treatment - pain at the site of exposure, paresthesia, headaches, fever, nausea and even the development of infectious processes in the wound. But, as doctors note, such complications are insignificant compared to the consequences that usually develop against the background of a sluggish wound process - we are talking about the danger of developing gangrene with subsequent amputation of the limb.
The risk of complications of trophic ulcers in diabetes is extremely high, so accelerating wound healing is a pressing issue for modern medicine. Scientific approval of a new shock wave device can help millions of patients around the world, and not only in the United States.
The information was published in the periodical Engadget.
[